Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: A longitudinal experimental study

Arthritis Research and Therapy

Volumn 11, Issue 2, 2009, Pages

  de Grauw, Janny C ^a   van de Lest, Chris H A ^b   van Weeren, Paul René ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; BIOLOGICAL MARKER; BRADYKININ; CARBOXYPROPEPTIDE OF TYPE II COLLAGEN; CHONDROITIN SULFATE EPITOPE 846; COLLAGEN TYPE 2; COLLAGENASE CLEAVAGE NEOEPITOPE OF TYPE II COLLAGEN; GLYCOSAMINOGLYCAN; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; PROSTAGLANDIN E2; SUBSTANCE P; UNCLASSIFIED DRUG; AUTACOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EXPERIMENTAL STUDY; HORSE; LONGITUDINAL STUDY; MALE; NONHUMAN; ONSET AGE; PATHOGENESIS; PROTEIN METABOLISM; SYNOVIAL FLUID; ANIMAL; ARTICULAR CARTILAGE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; METABOLISM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HORSES; INFLAMMATION MEDIATORS; SYNOVIAL FLUID;

EID: 63349093831     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2640     Document Type: Article

References (44)

1. Loeuille D Chary-Valckenaere I Champigneulle J Rat AC Toussaint F Pinzano-Watrin A Goebel JC Mainard D Blum A Pourel J Netter P Gillet P Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: Correlating magnetic resonance imaging findings with disease severity Arthritis Rheum 2005, 52:3492-3501. 10.1002/art.21373 16255041
2. Hill CL Hunter DJ Niu J Clancy M Guermazi A Genant H Gale D Grainger A Conaghan P Felson DT Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis Ann Rheum Dis 2007, 66:1599-1603. 10.1136/ard.2006.067470 17491096
3. Sutton S Clutterbuck A Harris P Gent T Freeman S Foster N Barrett-Jolley R Mobasheri A The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis Vet J 2009, 179:10-24. 17911037 10.1016/j.tvjl.2007.08.013
4. Scott-Lennox JA McLaughlin-Miley C Lennox RD Bohlig AM Cutler BL Yan C Jaffe M Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis Arthritis Rheum 2001, 44:1599-1607. 10.1002/ 1529-0131(200107)44:7<1599::AID-ART283>3.0.CO;2-N 11465711
5. Bauer DC Hunter DJ Abramson SB Attur M Corr M Felson D Heinegard D Jordan JM Kepler TB Lane NE Saxne T Tyree B Kraus VB Osteoarthritis Biomarkers Network Classification of osteoarthritis biomarkers: A proposed approach Osteoarthr Cartil 2006, 14:723-727. 10.1016/ j.joca.2006.04.001 16733093
6. Matyas JR Atley L Ionescu M Eyre DR Poole AR Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis Arthritis Rheum 2004, 50:543-552. 10.1002/art.20027 14872497
7. Lohmander LS Yoshihara Y Roos H Kobayashi T Yamada H Shinmei M Procollagen II C-propeptide in joint fluid: Changes in concentration with age, time after knee injury, and osteoarthritis J Rheumatol 1996, 23:1765-1769. 8895155
8. Henrotin Y Addison S Kraus V Deberg M Type II collagen markers in osteoarthritis: What do they indicate? Curr Opin Rheumatol 2007, 19:444-450. 10.1097/BOR.0b013e32829fb3b5 17762609
9. Fraser A Fearon U Billinghurst RC Ionescu M Reece R Barwick T Emery P Poole AR Veale DJ Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: Relationship to mediators of systemic and local inflammation Arthritis Rheum 2003, 48:3085-3095. 10.1002/art.11331 14613270
10. Ishiguro N Ito T Oguchi T Kojima T Iwata H Ionescu M Poole AR Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis Arthritis Rheum 2001, 44:2503-2511. 10.1002/ 1529-0131(200111)44:11<2503::AID-ART430>3.0.CO;2-P 11710706
11. Myers SL Brandt KD Eilam O Even low-grade synovitis significantly accelerates the clearance of protein from the canine knee. Implications for measurement of synovial fluid 'markers' of osteoarthritis Arthritis Rheum 1995, 38:1085-1091. 10.1002/art.1780380810 7639804
12. Kraus VB Huebner JL Fink C King JB Brown S Vail TP Guilak F Urea as a passive transport marker for arthritis biomarker studies Arthritis Rheum 2002, 46:420-427. 10.1002/art.10124 11840444
13. Poole AR An introduction to the pathophysiology of osteoarthritis Front Biosci 1999, 4:D662-D670. 10.2741/Poole 10525481
14. Garnero P Delmas PD Biomarkers in osteoarthritis Curr Opin Rheumatol 2003, 15:641-646. 10.1097/00002281-200309000-00020 12960494
15. Koch TG Betts DH Stem cell therapy for joint problems using the horse as a clinically relevant animal model Expert Opin Biol Ther 2007, 7:1621-1626. 17961087 10.1517/14712598.7.11.1621
16. Laverty S Sandy JD Celeste C Vachon P Marier JF Plaas AH Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses Arthritis Rheum 2005, 52:181-191. 15641100 10.1002/art.20762
17. Frisbie DD Ghivizzani SC Robbins PD Evans CH McIlwraith CW Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene Gene Ther 2002, 9:12-20. 11850718 10.1038/sj.gt.3301608
18. McIlwraith CW General pathobiology of the joint and response to injury Joint Disease in the Horse Philadelphia: W.B. Saunders McIlwraith CW, Trotter GW 1996:40-70.
19. Morton AJ Campbell NB Gayle JM Redding WR Blikslager AT Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis Res Vet Sci 2005, 78:189-192. 10.1016/j.rvsc.2004.07.006 15563928
20. Khumsap S Lanovaz JL Rosenstein DS Byron C Clayton HM Effect of induced unilateral synovitis of distal intertarsal and tarsometatarsal joints on sagittal plane kinematics and kinetics of trotting horses Am J Vet Res 2003, 64:1491-1495. 10.2460/ajvr.2003.64.1491 14672426
21. Meulyzer M Vachon P Beaudry F Vinardell T Richard H Beauchamp G Laverty S Joint inflammation increases glucosamine levels attained in synovial fluid following oral administration of glucosamine hydrochloride Osteoarthritis Cartilage 2009, 17:228-234. 18692410 10.1016/ j.joca.2008.06.018
22. Palmer JL Bertone AL Experimentally-induced synovitis as a model for acute synovitis in the horse Equine Vet J 1994, 26:492-495. 7889925
23. Ross MW The lameness score: Quantification of lameness severity Diagnosis and Management of Lameness in the Horse Philadelphia: W.B. Saunders Ross MW, Dyson SJ 2003:66-67.
24. Owens JG Kamerling SG Stanton SR Keowen ML Prescott-Mathews JS Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses Am J Vet Res 1996, 57:866-874. 8725815
25. de Grauw JC Brama PA Wiemer P Brommer H Lest van de CH van Weeren PR Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia Am J Vet Res 2006, 67:1156-1162. 10.2460/ajvr.67.7.1156 16817736
26. Neumann U Kubota H Frei K Ganu V Leppert D Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme Anal Biochem 2004, 328:166-173. 10.1016/ j.ab.2003.12.035 15113693
27. Rizkalla G Reiner A Bogoch E Poole AR Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease J Clin Invest 1992, 90:2268-2277. 443378 1281828 10.1172/JCI116113
28. Poole AR Ionescu M Swan A Dieppe PA Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis J Clin Invest 1994, 94:25-33. 296278 7518830 10.1172/JCI117314
29. Nelson F Dahlberg L Laverty S Reiner A Pidoux I Ionescu M Fraser GL Brooks E Tanzer M Rosenberg LC Dieppe P Poole AR Evidence for altered synthesis of type II collagen in patients with osteoarthritis J Clin Invest 1998, 102:2115-2125. 509166 9854047 10.1172/JCI4853
30. Kojima T Mwale F Yasuda T Girard C Poole AR Laverty S Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis Arthritis Rheum 2001, 44:120-127. 10.1002/ 1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-X 11212149
31. Song X Zeng L Jin W Thompson J Mizel DE Lei K Billinghurst RC Poole AR Wahl SM Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis J Exp Med 1999, 190:535-542. 2195606 10449524 10.1084/jem.190.4.535
32. Frisbie DD Ray CS Ionescu M Poole AR Chapman PL McIlwraith CW Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses Am J Vet Res 1999, 60:306-309. 10188811
33. Attur MG Dave M Akamatsu M Katoh M Amin AR Osteoarthritis or osteoarthrosis: The definition of inflammation becomes a semantic issue in the genomic era of molecular medicine Osteoarthr Cartil 2002, 10:1-4. 10.1053/joca.2001.0488 11795977
34. 2 values in horses Am J Vet Res 1993, 54:379-386. 8498739
35. Poole S Lorenzetti BB Cunha JM Cunha FQ Ferreira SH Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia Br J Pharmacol 1999, 126:649-656. 1565854 10188975 10.1038/sj.bjp.0702347
36. Ryu SY Jeong KS Yoon WK Park SJ Kang BN Kim SH Park BK Cho SW Somatostatin and substance P induced in vivo by lipopolysaccharide and in peritoneal macrophages stimulated with lipopolysaccharide or interferon-gamma have differential effects on murine cytokine production Neuroimmunomodulation 2000, 8:25-30. 10.1159/000026449 10859485
37. 2 exerts catabolic effects in osteoarthritis cartilage: Evidence for signaling via the EP4 receptor J Immunol 2008, 181:5082-5088. 18802112
38. Meini S Maggi CA Knee osteoarthritis: A role for bradykinin? Inflamm Res 2008, 57:351-361. 18787773 10.1007/s00011-007-7204-1
39. Chu Q Lopez M Hayashi K Ionescu M Billinghurst RC Johnson KA Poole AR Markel MD Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog Osteoarthr Cartil 2002, 10:662-669. 2048684 12479389 10.1053/joca.2002.0812
40. Lohmander LS Ionescu M Jugessur H Poole AR Changes in joint cartilage aggrecan after knee injury and in osteoarthritis Arthritis Rheum 1999, 42:534-544. 10.1002/ 1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J 10088777
41. Janusz MJ Little CB King LE Hookfin EB Brown KK Heitmeyer SA Caterson B Poole AR Taiwo YO Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration Osteoarthr Cartil 2004, 12:720-728. 10.1016/j.joca.2004.06.004 15325638
42. Todhunter PG Kincaid SA Todhunter RJ Kammermann JR Johnstone B Baird AN Hanson RR Wright JM Lin HC Purohit RC Immunohistochemical analysis of an equine model of synovitis-induced arthritis Am J Vet Res 1996, 57:1080-1093. 8807026
43. Hawkins DL Cargile JL MacKay RJ Broome TA Skelley LA Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin Am J Vet Res 1995, 56:1292-1299. 8928945
44. Petrov R MacDonald MH Tesch AM Benton HP Inhibition of adenosine kinase attenuates interleukin-1- and lipopolysaccharide-induced alterations in articular cartilage metabolism Osteoarthr Cartil 2005, 13:250-257. 10.1016/j.joca.2004.12.004 15727892